13-23341325-C-A
Variant summary
Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BP6
The NM_014363.6(SACS):c.2551G>T(p.Val851Phe) variant causes a missense change. The variant allele was found at a frequency of 0.00000934 in 1,606,044 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_014363.6 missense
Scores
Clinical Significance
Conservation
Publications
- Charlevoix-Saguenay spastic ataxiaInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), Myriad Women’s Health
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 1 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  0.0000526  AC: 8AN: 152162Hom.:  0  Cov.: 33 show subpopulations 
GnomAD4 exome  AF:  0.00000481  AC: 7AN: 1453882Hom.:  0  Cov.: 35 AF XY:  0.00000277  AC XY: 2AN XY: 722032 show subpopulations 
Age Distribution
GnomAD4 genome  0.0000526  AC: 8AN: 152162Hom.:  0  Cov.: 33 AF XY:  0.0000269  AC XY: 2AN XY: 74344 show subpopulations 
Age Distribution
ClinVar
Submissions by phenotype
Hereditary spastic paraplegia    Uncertain:1 
- -
not provided    Uncertain:1 
Available data are insufficient to determine the clinical significance of the variant at this time. The frequency of this variant in the general population is uninformative in assessment of its pathogenicity. (http://gnomad.broadinstitute.org) Polyphen and MutationTaster yielded discordant predictions regarding whether this amino acid change is damaging to the protein. -
Charlevoix-Saguenay spastic ataxia    Uncertain:1 
- -
Spastic paraplegia    Benign:1 
- -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at